drugset / Trial / NCT07229157
Effect of Maridebart Cafraglutide on the Heart's Electrical Activity
RandomizedCrossoverDouble-blindBasic science
Summary
The main objective of this trial is to evaluate the effect of maridebart cafraglutide subcutaneously (SC) on the placebo-corrected, change from baseline in QT interval corrected for heart rate using Fridericia's formula in participants living with overweight or obesity.
Timeline
- Start
- 2025-10-22
- Primary completion
- 2026-08-27
- Completion
- 2026-08-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Maridebart Cafraglutide | Unknown | — | Subcutaneous |
| Subject | Moxifloxacin | Small molecule | — | Oral |